Sign in

You're signed outSign in or to get full access.

Lon Bell

Director at EXOZYMES
Board

About Lon Bell

Lon Edward Bell, PhD (age 84) joined EXOZ’s Board on April 1, 2024 as an independent director and currently chairs the Audit Committee; he is designated the Board’s “financial expert.” Bell holds BS, MS, and PhD degrees from Caltech and has over five decades of operating and board experience in thermal management and materials companies .

Past Roles

OrganizationRoleTenureCommittees/Impact
Amerigon (now Gentherm, NASDAQ: THRM)Founder; built solid-state thermal management supplier to auto industry1991 onward (company evolution); prior ventures led to founding AmerigonCommercialized thermoelectric systems; multiple patents brought to mass production
Technar, IncorporatedFounder; led crash sensor supplier; sold to TRW1968–1991 (sale to TRW in 1991)Pioneered automotive crash sensors; exit to TRW
Caltech Dept. of Mechanical & Civil EngineeringAdvisory Board member; Chair2008–present; Chair 2015–2022Academic governance and industry linkage

External Roles

OrganizationRoleTenureNotes
DTP Thermoelectrics LLCFounder & CEO2021–presentCommercializing next-gen solid-state heating/cooling systems
CDTi Advanced Materials, Inc. (CDTI: Pink Sheet)Chairman of the Board2017–present; prior Board member 2013–2016Pivot to catalytic coating systems for hydrogen economy and sequestration industries

Board Governance

  • Independence: Board determined Lon Bell is independent under Nasdaq and SEC rules .
  • Committee assignments: Chair, Audit Committee; member, Compensation Committee; member, Nominating Committee. Audit Committee members are all independent (Bell, Bowie, Lalonde), with Bell designated “financial expert” .
  • Attendance: In FY2024, the Board met four times; each incumbent director attended at least 75% of Board and applicable committee meetings .
  • Audit Committee report: Confirmed oversight of audited FY2024 financials, PCAOB-required communications, and auditor independence; recommended inclusion of audited statements in 2024 Form 10-K .
  • Board leadership: Chairman is Christopher Marlett; CEO and Chair roles are separated .

Fixed Compensation

Director compensation disclosed for 2024 (partial-year onboarding for Bell):

Metric20232024
Annual retainer/fees ($)8,333

Notes:

  • Company states it has no defined director compensation plan; independent director compensation determined at appointment and thereafter; reasonable expenses reimbursed .

Performance Compensation

Director equity awarded (fair value):

Metric20232024
Option Awards ($ fair value)51,939

Performance metrics tied to director compensation: Not disclosed. The 2025 Equity Plan permits performance-based awards using objective measures (e.g., EPS, revenues/margins, cash flow, operating margin, ROIC/ROE, EBITDA, TSR, market share, debt reduction), but no performance conditions are specified for director grants .

Other Directorships & Interlocks

CompanyExchangeRolePotential Interlock/Conflict
CDTi Advanced Materials, Inc.Pink Sheet (CDTI)ChairmanDifferent industry (catalytic coatings vs. EXOZ enzymes); no disclosed related-party link to EXOZ

MDB Capital Holdings, LLC is EXOZ’s former parent and controlling shareholder (48.25%); two MDB principals (Marlett, DiGiandomenico) and an MDB affiliate employee (Rayo) sit on EXOZ’s Board—Audit Committee reviews related-party transactions .

Expertise & Qualifications

  • Financial expertise designated by the Board; chairs Audit Committee .
  • Deep technical/operational background in thermoelectrics and automotive systems; >100 patents, with multiple clusters in mass production .
  • Governance experience across public, private, and academic boards .

Equity Ownership

HolderShares Beneficially Owned% OutstandingNotes
Lon Edward Bell12,1190.14%No option holdings disclosed for Bell in ownership table; no pledging disclosures

Company-level ownership and related-party context:

  • MDB Capital Holdings, LLC beneficially owns 4,136,426 shares (48.14%); Marlett and DiGiandomenico have voting/dispositive control .
  • Related-party loan from MDB settled post-IPO; remaining payable expected to be paid in 2025 (no interest) .

Insider Trades

DateFilingTransactionSharesPriceNotes
Proxy reports Section 16 compliance and no adoption/termination of Rule 10b5-1 plans in last fiscal quarter; specific Form 4 transactions for Bell not disclosed in proxy .

Insider trading policy: Pre-clearance required; blackout periods around SEC filings; prohibited use of MNPI .

Governance Assessment

  • Strengths:

    • Audit Committee chaired by an independent “financial expert” (Bell), with clear oversight of financial reporting, auditor independence, and related-party transaction review .
    • Separation of CEO and Chair roles; documented clawback policy compliant with SEC rules .
    • Director attendance at least 75% across Board/committees .
  • Concerns/RED FLAGS:

    • Concentrated control by former parent MDB (48%+), with multiple MDB-affiliated directors (Marlett, DiGiandomenico, Rayo) on EXOZ’s Board—heightened risk of influence over compensation, capital allocation, and related-party dealings despite Audit Committee oversight .
    • Director compensation for independents appears modest and equity-heavy; absence of disclosed performance conditions may reduce pay-for-performance linkage for directors (though performance awards are enabled under the 2025 Plan) .
    • Independence disclosure states a “majority” of directors are independent while identifying three of six as non-independent; ongoing monitoring advisable given control dynamics .
  • Net view:

    • Bell’s audit leadership and financial expertise are positives for board effectiveness and investor confidence. Oversight of related-party transactions is critical given MDB’s control; continued transparency on director equity grant terms, any performance conditions, and insider trading activity will be important to mitigate perceived conflicts .